These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 14508724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Second line therapies move to the forefront in colorectal cancer.
    Miller M.
    J Natl Cancer Inst; 1999 Jun 16; 91(12):998-1000. PubMed ID: 10379961
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement by Bartlett et al.
    Chari RS, Helton WS, Marsh RD.
    Ann Surg Oncol; 2006 Oct 16; 13(10):1293-5. PubMed ID: 16952023
    [No Abstract] [Full Text] [Related]

  • 5. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb 16; 2(4):205-9. PubMed ID: 12620138
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
    Pasetto LM, Merenda R, Pilati P, Sinigaglia G, Monfardini S.
    Anticancer Res; 2006 Feb 16; 26(6C):4785-92. PubMed ID: 17214342
    [Abstract] [Full Text] [Related]

  • 7. Hepatic artery infusion for liver metastases from colorectal cancer.
    Bonetti A.
    Lancet; 2003 Feb 01; 361(9355):358-9. PubMed ID: 12573366
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Application and problems in hepatic arterial infusion chemotherapy].
    Nagao M, Nakajima Y.
    Nihon Rinsho; 2003 Sep 01; 61 Suppl 7():329-32. PubMed ID: 14574905
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.
    Nielsen DL, Palshof JA, Larsen FO, Jensen BV, Pfeiffer P.
    Cancer Treat Rev; 2014 Jul 01; 40(6):701-15. PubMed ID: 24731471
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regional chemotherapy for liver-limited metastatic colorectal cancer.
    Power DG, Healey-Bird BR, Kemeny NE.
    Clin Colorectal Cancer; 2008 Jul 01; 7(4):247-59. PubMed ID: 18650193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDA drug approval summaries: oxaliplatin.
    Ibrahim A, Hirschfeld S, Cohen MH, Griebel DJ, Williams GA, Pazdur R.
    Oncologist; 2004 Jul 01; 9(1):8-12. PubMed ID: 14755010
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic treatment of colorectal cancer.
    Wolpin BM, Mayer RJ.
    Gastroenterology; 2008 May 01; 134(5):1296-310. PubMed ID: 18471507
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.